Literature DB >> 24270251

Clinical variables associated with leprosy reactions and persistence of physical impairment.

Daniela Teles de Oliveira, Jonnia Sherlock, Enaldo Vieira de Melo, Karla Caroline Vieira Rollemberg, Telma Rodrigues Santos da Paixão, Yasmin Gama Abuawad, Marise do Vale Simon, Malcolm Duthie, Amelia Ribeiro de Jesus.   

Abstract

INTRODUCTION: Leprosy is a chronic disease that affects skin and peripheral nerves. Disease complications include reactional episodes and physical impairment. One World Health Organization (WHO) goal of leprosy programs is to decrease the number of grade 2 impairment diagnoses by 2015. This study aims to evaluate clinical factors associated with the occurrence of leprosy reactions and physical impairment in leprosy patients.
METHODS: We conducted a retrospective study of data from medical records of patients followed in two important centers for the treatment of leprosy in Aracaju, Sergipe, Brazil, from 2005 to 2011. We used the chi-square test to analyze associations between the following categorical variables: gender, age, operational classification, clinical forms, leprosy reactions, corticosteroid treatment, and physical impairment at the diagnosis and after cure. Clinical variables associated with multibacillary leprosy and/or reactional episodes and the presence of any grade of physical impairment after cure were evaluated using the logistic regression model.
RESULTS: We found that men were more affected by multibacillary forms, reactional episodes, and grade 2 physical impairment at diagnosis. Leprosy reactions were detected in a total of 40% of patients and all were treated with corticosteroids. However, physical impairment was observed in 29.8% of the patients analyzed at the end of the treatment and our multivariate analysis associated a low dose and short period of corticosteroid treatment with persistence of physical impairments.
CONCLUSIONS: Physical impairment should receive an increased attention before and after treatment, and adequate treatment should be emphasized.

Entities:  

Mesh:

Year:  2013        PMID: 24270251     DOI: 10.1590/0037-8682-0100-2013

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  6 in total

1.  Genetic polymorphisms of the IL6 and NOD2 genes are risk factors for inflammatory reactions in leprosy.

Authors:  Carolinne Sales-Marques; Cynthia Chester Cardoso; Lucia Elena Alvarado-Arnez; Ximena Illaramendi; Anna Maria Sales; Mariana de Andréa Hacker; Mayara Garcia de Mattos Barbosa; José Augusto da Costa Nery; Roberta Olmo Pinheiro; Euzenir Nunes Sarno; Antonio Guilherme Pacheco; Milton Ozório Moraes
Journal:  PLoS Negl Trop Dis       Date:  2017-07-17

2.  sCD163 levels as a biomarker of disease severity in leprosy and visceral leishmaniasis.

Authors:  Ricardo Luís Louzada Silva; Marcio B Santos; Priscila L S Almeida; Thayse S Barros; Lucas Magalhães; Rodrigo A Cazzaniga; Patrícia R M Souza; Nívea F Luz; Jaqueline França-Costa; Valeria M Borges; Djalma S Lima-Junior; Michael W Lipscomb; Malcolm S Duthie; Steven G Reed; Roque Pacheco Almeida; Amélia Ribeiro Jesus
Journal:  PLoS Negl Trop Dis       Date:  2017-03-29

3.  Leprosy Reactions In Childhood: A Prospective Cohort Study In The Brazilian Amazon.

Authors:  Sabrina Sampaio Bandeira; Carla Avelar Pires; Juarez Antonio Simões Quaresma
Journal:  Infect Drug Resist       Date:  2019-10-17       Impact factor: 4.003

4.  Risk factors for physical disability in patients with leprosy disease in Yunnan, China: Evidence from a retrospective observational study.

Authors:  Xiaohua Chen; Hong-Bing Liu; Tie-Jun Shui; Shun Zha
Journal:  PLoS Negl Trop Dis       Date:  2021-11-10

5.  The burden of physical disability among patients with newly detected leprosy in Yunnan, China, 1990-2020: A population-based, cross-sectional survey.

Authors:  Xiaohua Chen; Tie-Jun Shui
Journal:  PLoS Negl Trop Dis       Date:  2022-10-11

6.  IL-10 and NOS2 modulate antigen-specific reactivity and nerve infiltration by T cells in experimental leprosy.

Authors:  Deanna A Hagge; David M Scollard; Nashone A Ray; Vilma T Marks; Angelina T Deming; John S Spencer; Linda B Adams
Journal:  PLoS Negl Trop Dis       Date:  2014-09-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.